Your session is about to expire
← Back to Search
CALM Intervention for Brain Cancer
Study Summary
This trial will help to identify how the CALM intervention can be adapted to help service members, Veterans, and civilians who have cancer that has spread to the brain.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- It has been over 2 weeks since my brain surgery or biopsy.My medical records confirm I have brain metastasis.I cannot use an electronic device for telehealth sessions.I am able to understand and sign the consent form.My thinking and memory test score is above 20.
- Group 1: CALM
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What objectives are researchers aiming to fulfill through this trial?
"The primary aim of this 3 month trial is to assess the feasibility of CALM intervention. Secondary outcomes encompass changes in suicidal ideation, as measured by Patient Health Questionnaire-9 (PHQ-9), clinical evaluation via Clinical Evaluation Questionnaire (CEQ) and death distress assessed through Death and Dying Distress Scale (DADDS). PHQ-9 scores range from 0 indicating no depression up to 27 for severe depression, CEQ measures emotional support experienced during treatment with a score between 1 and 5 while DADDS evaluates levels of death anxiety ranging from mild at 25 points and rising to extreme distress above 47."
Is there any availability to join this health experiment?
"Indeed, according to records on clinicaltrials.gov this ongoing medical trial commenced recruitment on March 23rd 2022 and has recently been updated. The research team is looking for 60 patients from two different locations."
How many participants are eligible for this clinical trial?
"Affirmative. Clinicaltrials.gov data reveals that this clinical trial is currently recruiting patients, with the initial announcement on March 23rd 2022 and a most recent update made April 5th 2022. The two locations are seeking to enrol 60 participants combined in total."
Share this study with friends
Copy Link
Messenger